Tech Company Financing Transactions
Millendo Therapeutics Funding Round
Millendo Therapeutics, operating out of Ann Arbor, raised $16 million from 5AM Ventures, Frazier Healthcare Partners and private investors.
Transaction Overview
Company Name
Announced On
8/6/2012
Transaction Type
Venture Equity
Amount
$16,000,000
Round
Series A
Investors
5AM Ventures (Lead Investor)
Frazier Healthcare Partners (Lead Investor) (James Topper)
Proceeds Purpose
Frazier Healthcare and 5AM Ventures led the round and proceeds from the financing will support Atterocor's accelerated development of its lead program.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
110 Miller Ave. 100
Ann Arbor, MI 48104
USA
Ann Arbor, MI 48104
USA
Phone
Website
Email Address
Overview
Millendo Therapeutics is focused on developing a portfolio of disease-modifying treatments for endocrine disorders caused by hormone dysregulation. Our product candidates seek to improve the quality of life for patients with orphan and specialty diseases with limited or no approved treatment options.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Julia Owens
Chief Financial Officer
Louis Arcudi
Chief Medical Officer
Christophe Arbet-Engels
VP - Bus. Development
Thomas Hoover
VP - Bus. Development
Ryan Zeidan
VP - General Counsel
Tamara Joseph
Browse more venture capital transactions:
Prev: 8/6/2012: DNAtriX venture capital transaction
Next: 8/7/2012: LaunchBit venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs